| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RDEA119 | FIMM | pan-cancer | AAC | -0.016 | 0.9 |
| mRNA | Bicalutamide | FIMM | pan-cancer | AAC | 0.016 | 0.9 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | 0.0037 | 0.9 |
| mRNA | BIBW2992 | FIMM | pan-cancer | AAC | -0.014 | 0.9 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | -0.0029 | 0.9 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.004 | 0.9 |
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.0049 | 0.9 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | 0.0027 | 0.9 |